Evidence map›Paper›PMID 34066651›Full record

ArticleCurrent oncology (Toronto, Ont.)2021

Impact of an Augmented Reality Navigation System (SIRIO) on Bone Percutaneous Procedures: A Comparative Analysis with Standard CT-Guided Technique.

Eliodoro Faiella, Gennaro Castiello, Caterina Bernetti, Giuseppina Pacella, Carlo Altomare, Flavio Andresciani, Bruno Beomonte Zobel, Rosario Francesco Grasso

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Bone biopsies guided by augmented reality: a pilot study.European radiology experimental · 2023
    Article
  11. Treatment of Bone Metastasis.Current oncology (Toronto, Ont.) · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eliodoro FaiellaDepartment of Diagnostic and Interventional Radiology, Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
Gennaro CastielloDepartment of Diagnostic and Interventional Radiology, Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.ORCID 0000-0003-3046-313X
Caterina BernettiDepartment of Diagnostic and Interventional Radiology, Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
Giuseppina PacellaDepartment of Diagnostic and Interventional Radiology, Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
Carlo AltomareDepartment of Diagnostic and Interventional Radiology, Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
Flavio AndrescianiDepartment of Diagnostic and Interventional Radiology, Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.ORCID 0000-0003-2953-1094
Bruno Beomonte ZobelDepartment of Diagnostic and Interventional Radiology, Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.ORCID 0000-0001-9227-5535
Rosario Francesco GrassoDepartment of Diagnostic and Interventional Radiology, Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The purpose of this study is to evaluate the impact of an augmented reality navigation system (SIRIO) for percutaneous biopsies and ablative treatments on bone lesions, compared to a standard CT-guided technique. (2) Methods: Bioptic and ablative procedures on bone lesions were retrospectively analyzed. All procedures were divided into SIRIO and Non-SIRIO groups and in <2 cm and >2 cm groups. Number of CT-scans, procedural time and patient's radiation dose were reported for each group. Diagnostic accuracy was obtained for bioptic procedures. (3) Results: One-hundred-ninety-three procedures were evaluated: 142 biopsies and 51 ablations. Seventy-four biopsy procedures were performed using SIRIO and 68 under standard CT-guidance; 27 ablative procedures were performed using SIRIO and 24 under standard CT-guidance. A statistically significant reduction in the number of CT-scans, procedural time and radiation dose was observed for percutaneous procedures performed using SIRIO, in both <2 cm and >2 cm groups. The greatest difference in all variables examined was found for procedures performed on lesions <2 cm. Higher diagnostic accuracy was found for all SIRIO-assisted biopsies. No major or minor complications occurred in any procedures. (4) Conclusions: The use of SIRIO significantly reduces the number of CT-scans, procedural time and patient's radiation dose in CT-guided percutaneous bone procedures, particularly for lesions <2 cm. An improvement in diagnostic accuracy was also achieved in SIRIO-assisted biopsies.

Indexed as

Augmented RealityCarbidopaDrug CombinationsHumansImage-Guided BiopsyLevodopaRetrospective StudiesTomography, X-Ray ComputedCarbidopaDrug CombinationsLevodopasirioablation techniquesbiopsybone neoplasmComputed Tomographyoptical tracking

Identifiers

PMID34066651
PMCPMC8161791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.